YELLOW FEVER VIRUS
|
Structure
& Property |
Transmission |
Pathogenesis |
Clinical
findings |
Laboratory
diagnosis |
Treatment |
|
Family: flavivirus Genome: single-strand, +ve polarity RNA. Size: 40-50nm Icosahedral nucleocapsid. Enveloped virion Single serotype |
Endemic in South America and West Africa. Two forms: - urban: disease of humans transmitted by mosquito Aedes aegypti, which breeds in stagnant water. - jungle: disease of monkeys transmitted by treetop mosquitoes of haemagogus species. |
Most important arbovirus haemorrhagic fever, being the most severe, in which liver involvement and jaundice are prominent features. No chronic infection. Lifelong immunity. |
Begins with sudden onset of fever, headache, myalgias & photophobia. After prodrome, symptoms progress to involve the liver, kidneys, and heart. Prostration and shock accompanied by upper gastrointestinal tract hemorrhage with hematemesis, follows. Complication: toxic nephrosis with proteinuria. |
Diagnosis: - haemagglutiation-inhibition for rise in antibody titer. - IgM and IgG ELISA |
No antiviral therapy and mortality rate is high. Yellow fever vaccine: - contains live attenuated virus of a strain 17D, attenuated by repeated passage in chick embryos. - administration in one dose by subcutaneous injection. - provides good, solid immunity for at least 10 years. - free from side effects. |